Index by author

January 01 1999; volume 22 issue 1

A

  1. Aaser, E

    1. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.
      J V Bjørnholt, G Erikssen, E Aaser, L Sandvik, S Nitter-Hauge, J Jervell, J Erikssen and E Thaulow
      Diabetes Care 1999 Jan; 22 (1): 45-49. https://doi.org/10.2337/diacare.22.1.45

  2. Arcari, R

    1. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.
      G Bruno, A De Salvia, R Arcari, M Borra, N Grosso, Q Carta, M Trovati, M Veglio and G Pagano
      Diabetes Care 1999 Jan; 22 (1): 50-55. https://doi.org/10.2337/diacare.22.1.50

  3. Asp, N G

    1. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.
      A E Järvi, B E Karlström, Y E Granfeldt, I E Björck, N G Asp and B O Vessby
      Diabetes Care 1999 Jan; 22 (1): 10-18. https://doi.org/10.2337/diacare.22.1.10

  4. Aubert, R E

    1. Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes.
      R Sikka, J Waters, W Moore, D R Sutton, W H Herman and R E Aubert
      Diabetes Care 1999 Jan; 22 (1): 1-6. https://doi.org/10.2337/diacare.22.1.1

B

  1. Barnes, R B

    1. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
      D A Ehrmann, R B Barnes, R L Rosenfield, M K Cavaghan and J Imperial
      Diabetes Care 1999 Jan; 22 (1): 141-146. https://doi.org/10.2337/diacare.22.1.141

  2. Benhamou, P Y

    1. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
      G Vanzetto, S Halimi, T Hammoud, D Fagret, P Y Benhamou, D Cordonnier, B Denis and J Machecourt
      Diabetes Care 1999 Jan; 22 (1): 19-26. https://doi.org/10.2337/diacare.22.1.19

  3. Berglund, L

    1. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
      F Wollesen, G Dahlén, L Berglund and C Berne
      Diabetes Care 1999 Jan; 22 (1): 93-98. https://doi.org/10.2337/diacare.22.1.93

  4. Berne, C

    1. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
      F Wollesen, G Dahlén, L Berglund and C Berne
      Diabetes Care 1999 Jan; 22 (1): 93-98. https://doi.org/10.2337/diacare.22.1.93

  5. Björck, I E

    1. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.
      A E Järvi, B E Karlström, Y E Granfeldt, I E Björck, N G Asp and B O Vessby
      Diabetes Care 1999 Jan; 22 (1): 10-18. https://doi.org/10.2337/diacare.22.1.10

  6. Bjørnholt, J V

    1. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.
      J V Bjørnholt, G Erikssen, E Aaser, L Sandvik, S Nitter-Hauge, J Jervell, J Erikssen and E Thaulow
      Diabetes Care 1999 Jan; 22 (1): 45-49. https://doi.org/10.2337/diacare.22.1.45

  7. Black, S A

    1. Increased health burden associated with comorbid depression in older diabetic Mexican Americans. Results from the Hispanic Established Population for the Epidemiologic Study of the Elderly survey.
      S A Black
      Diabetes Care 1999 Jan; 22 (1): 56-64. https://doi.org/10.2337/diacare.22.1.56

  8. Bloomgarden, Z T

    1. American Diabetes Association Annual Meeting, 1998. Treatment of type 2 diabetes.
      Z T Bloomgarden
      Diabetes Care 1999 Jan; 22 (1): 170-174. https://doi.org/10.2337/diacare.22.1.170

  9. Boomsma, L J

    1. Prevalence of deafness is increased in patients with type 2 diabetes in The Netherlands.
      R P Stolk and L J Boomsma
      Diabetes Care 1999 Jan; 22 (1): 180. https://doi.org/10.2337/diacare.22.1.180

  10. Borra, M

    1. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.
      G Bruno, A De Salvia, R Arcari, M Borra, N Grosso, Q Carta, M Trovati, M Veglio and G Pagano
      Diabetes Care 1999 Jan; 22 (1): 50-55. https://doi.org/10.2337/diacare.22.1.50

  11. Boulton, A J

    1. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
      G E Reiber, L Vileikyte, E J Boyko, M del Aguila, D G Smith, L A Lavery and A J Boulton
      Diabetes Care 1999 Jan; 22 (1): 157-162. https://doi.org/10.2337/diacare.22.1.157

  12. Boyages, S

    1. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
      R Moses, R Slobodniuk, S Boyages, S Colagiuri, W Kidson, J Carter, T Donnelly, P Moffitt and H Hopkins
      Diabetes Care 1999 Jan; 22 (1): 119-124. https://doi.org/10.2337/diacare.22.1.119

  13. Boyko, E J

    1. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
      G E Reiber, L Vileikyte, E J Boyko, M del Aguila, D G Smith, L A Lavery and A J Boulton
      Diabetes Care 1999 Jan; 22 (1): 157-162. https://doi.org/10.2337/diacare.22.1.157
    2. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans.
      M J McNeely, E J Boyko, D S Weigle, J B Shofer, S D Chessler, D L Leonnetti and W Y Fujimoto
      Diabetes Care 1999 Jan; 22 (1): 65-70. https://doi.org/10.2337/diacare.22.1.65

  14. Brismar, K

    1. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers.
      M Kalani, K Brismar, B Fagrell, J Ostergren and G Jörneskog
      Diabetes Care 1999 Jan; 22 (1): 147-151. https://doi.org/10.2337/diacare.22.1.147

  15. Brown, J B

    1. First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization.
      J V Selby, B Ettinger, B E Swain and J B Brown
      Diabetes Care 1999 Jan; 22 (1): 38-44. https://doi.org/10.2337/diacare.22.1.38

  16. Bruno, G

    1. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.
      G Bruno, A De Salvia, R Arcari, M Borra, N Grosso, Q Carta, M Trovati, M Veglio and G Pagano
      Diabetes Care 1999 Jan; 22 (1): 50-55. https://doi.org/10.2337/diacare.22.1.50

  17. Burge, M R

    1. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
      A G Rassam, T M Zeise, M R Burge and D S Schade
      Diabetes Care 1999 Jan; 22 (1): 133-136. https://doi.org/10.2337/diacare.22.1.133

C

  1. Carta, Q

    1. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.
      G Bruno, A De Salvia, R Arcari, M Borra, N Grosso, Q Carta, M Trovati, M Veglio and G Pagano
      Diabetes Care 1999 Jan; 22 (1): 50-55. https://doi.org/10.2337/diacare.22.1.50

  2. Carter, J

    1. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
      R Moses, R Slobodniuk, S Boyages, S Colagiuri, W Kidson, J Carter, T Donnelly, P Moffitt and H Hopkins
      Diabetes Care 1999 Jan; 22 (1): 119-124. https://doi.org/10.2337/diacare.22.1.119

  3. Cattalini, N

    1. Diabetic ketoacidosis associated with clozapine treatment.
      A Colli, M Cocciolo, F Francobandiera, F Rogantin and N Cattalini
      Diabetes Care 1999 Jan; 22 (1): 176-177. https://doi.org/10.2337/diacare.22.1.176a

  4. Cavaghan, M K

    1. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
      D A Ehrmann, R B Barnes, R L Rosenfield, M K Cavaghan and J Imperial
      Diabetes Care 1999 Jan; 22 (1): 141-146. https://doi.org/10.2337/diacare.22.1.141

  5. Chan, N N

    1. Lactic acidosis with therapeutic metformin blood level in a low-risk diabetic patient.
      N N Chan, D Darko and D O'Shea
      Diabetes Care 1999 Jan; 22 (1): 178. https://doi.org/10.2337/diacare.22.1.178b

  6. Chessler, S D

    1. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans.
      M J McNeely, E J Boyko, D S Weigle, J B Shofer, S D Chessler, D L Leonnetti and W Y Fujimoto
      Diabetes Care 1999 Jan; 22 (1): 65-70. https://doi.org/10.2337/diacare.22.1.65

  7. Chiarelli, F

    1. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices.
      M Vanelli, G Chiari, L Ghizzoni, G Costi, T Giacalone and F Chiarelli
      Diabetes Care 1999 Jan; 22 (1): 7-9. https://doi.org/10.2337/diacare.22.1.7

  8. Chiari, G

    1. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices.
      M Vanelli, G Chiari, L Ghizzoni, G Costi, T Giacalone and F Chiarelli
      Diabetes Care 1999 Jan; 22 (1): 7-9. https://doi.org/10.2337/diacare.22.1.7

  9. Choi, H

    1. Social environment and year of birth influence type 1 diabetes risk for African-American and Latino children.
      R B Lipton, M Drum, S Li and H Choi
      Diabetes Care 1999 Jan; 22 (1): 78-85. https://doi.org/10.2337/diacare.22.1.78

  10. Cocciolo, M

    1. Diabetic ketoacidosis associated with clozapine treatment.
      A Colli, M Cocciolo, F Francobandiera, F Rogantin and N Cattalini
      Diabetes Care 1999 Jan; 22 (1): 176-177. https://doi.org/10.2337/diacare.22.1.176a

  11. Colagiuri, S

    1. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
      R Moses, R Slobodniuk, S Boyages, S Colagiuri, W Kidson, J Carter, T Donnelly, P Moffitt and H Hopkins
      Diabetes Care 1999 Jan; 22 (1): 119-124. https://doi.org/10.2337/diacare.22.1.119

  12. Colli, A

    1. Diabetic ketoacidosis associated with clozapine treatment.
      A Colli, M Cocciolo, F Francobandiera, F Rogantin and N Cattalini
      Diabetes Care 1999 Jan; 22 (1): 176-177. https://doi.org/10.2337/diacare.22.1.176a

  13. Cordonnier, D

    1. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
      G Vanzetto, S Halimi, T Hammoud, D Fagret, P Y Benhamou, D Cordonnier, B Denis and J Machecourt
      Diabetes Care 1999 Jan; 22 (1): 19-26. https://doi.org/10.2337/diacare.22.1.19

  14. Costi, G

    1. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices.
      M Vanelli, G Chiari, L Ghizzoni, G Costi, T Giacalone and F Chiarelli
      Diabetes Care 1999 Jan; 22 (1): 7-9. https://doi.org/10.2337/diacare.22.1.7

D

  1. Dahlén, G

    1. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
      F Wollesen, G Dahlén, L Berglund and C Berne
      Diabetes Care 1999 Jan; 22 (1): 93-98. https://doi.org/10.2337/diacare.22.1.93

  2. Darko, D

    1. Lactic acidosis with therapeutic metformin blood level in a low-risk diabetic patient.
      N N Chan, D Darko and D O'Shea
      Diabetes Care 1999 Jan; 22 (1): 178. https://doi.org/10.2337/diacare.22.1.178b

  3. del Aguila, M

    1. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
      G E Reiber, L Vileikyte, E J Boyko, M del Aguila, D G Smith, L A Lavery and A J Boulton
      Diabetes Care 1999 Jan; 22 (1): 157-162. https://doi.org/10.2337/diacare.22.1.157

  4. Denis, B

    1. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
      G Vanzetto, S Halimi, T Hammoud, D Fagret, P Y Benhamou, D Cordonnier, B Denis and J Machecourt
      Diabetes Care 1999 Jan; 22 (1): 19-26. https://doi.org/10.2337/diacare.22.1.19

  5. De Salvia, A

    1. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.
      G Bruno, A De Salvia, R Arcari, M Borra, N Grosso, Q Carta, M Trovati, M Veglio and G Pagano
      Diabetes Care 1999 Jan; 22 (1): 50-55. https://doi.org/10.2337/diacare.22.1.50

  6. Donnelly, T

    1. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
      R Moses, R Slobodniuk, S Boyages, S Colagiuri, W Kidson, J Carter, T Donnelly, P Moffitt and H Hopkins
      Diabetes Care 1999 Jan; 22 (1): 119-124. https://doi.org/10.2337/diacare.22.1.119

  7. Drum, M

    1. Social environment and year of birth influence type 1 diabetes risk for African-American and Latino children.
      R B Lipton, M Drum, S Li and H Choi
      Diabetes Care 1999 Jan; 22 (1): 78-85. https://doi.org/10.2337/diacare.22.1.78

  8. Dunger, D B

    1. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.
      A Mohn, K A Matyka, D A Harris, K M Ross, J A Edge and D B Dunger
      Diabetes Care 1999 Jan; 22 (1): 27-32. https://doi.org/10.2337/diacare.22.1.27

E

  1. Edge, J A

    1. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.
      A Mohn, K A Matyka, D A Harris, K M Ross, J A Edge and D B Dunger
      Diabetes Care 1999 Jan; 22 (1): 27-32. https://doi.org/10.2337/diacare.22.1.27

  2. Ehrmann, D A

    1. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
      D A Ehrmann, R B Barnes, R L Rosenfield, M K Cavaghan and J Imperial
      Diabetes Care 1999 Jan; 22 (1): 141-146. https://doi.org/10.2337/diacare.22.1.141

  3. Elliott, T

    1. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
      G S Meneilly and T Elliott
      Diabetes Care 1999 Jan; 22 (1): 112-118. https://doi.org/10.2337/diacare.22.1.112

  4. Erikssen, G

    1. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.
      J V Bjørnholt, G Erikssen, E Aaser, L Sandvik, S Nitter-Hauge, J Jervell, J Erikssen and E Thaulow
      Diabetes Care 1999 Jan; 22 (1): 45-49. https://doi.org/10.2337/diacare.22.1.45

  5. Erikssen, J

    1. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.
      J V Bjørnholt, G Erikssen, E Aaser, L Sandvik, S Nitter-Hauge, J Jervell, J Erikssen and E Thaulow
      Diabetes Care 1999 Jan; 22 (1): 45-49. https://doi.org/10.2337/diacare.22.1.45

  6. Ettinger, B

    1. First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization.
      J V Selby, B Ettinger, B E Swain and J B Brown
      Diabetes Care 1999 Jan; 22 (1): 38-44. https://doi.org/10.2337/diacare.22.1.38

F

  1. Fagrell, B

    1. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers.
      M Kalani, K Brismar, B Fagrell, J Ostergren and G Jörneskog
      Diabetes Care 1999 Jan; 22 (1): 147-151. https://doi.org/10.2337/diacare.22.1.147

  2. Fagret, D

    1. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
      G Vanzetto, S Halimi, T Hammoud, D Fagret, P Y Benhamou, D Cordonnier, B Denis and J Machecourt
      Diabetes Care 1999 Jan; 22 (1): 19-26. https://doi.org/10.2337/diacare.22.1.19

  3. Falkner, B

    1. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
      A E Sumner, H Kushner, K D Sherif, T N Tulenko, B Falkner and J B Marsh
      Diabetes Care 1999 Jan; 22 (1): 71-77. https://doi.org/10.2337/diacare.22.1.71

  4. Francobandiera, F

    1. Diabetic ketoacidosis associated with clozapine treatment.
      A Colli, M Cocciolo, F Francobandiera, F Rogantin and N Cattalini
      Diabetes Care 1999 Jan; 22 (1): 176-177. https://doi.org/10.2337/diacare.22.1.176a

  5. Fujimoto, W Y

    1. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans.
      M J McNeely, E J Boyko, D S Weigle, J B Shofer, S D Chessler, D L Leonnetti and W Y Fujimoto
      Diabetes Care 1999 Jan; 22 (1): 65-70. https://doi.org/10.2337/diacare.22.1.65

G

  1. Ghizzoni, L

    1. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices.
      M Vanelli, G Chiari, L Ghizzoni, G Costi, T Giacalone and F Chiarelli
      Diabetes Care 1999 Jan; 22 (1): 7-9. https://doi.org/10.2337/diacare.22.1.7

  2. Giacalone, T

    1. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices.
      M Vanelli, G Chiari, L Ghizzoni, G Costi, T Giacalone and F Chiarelli
      Diabetes Care 1999 Jan; 22 (1): 7-9. https://doi.org/10.2337/diacare.22.1.7

  3. Granfeldt, Y E

    1. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.
      A E Järvi, B E Karlström, Y E Granfeldt, I E Björck, N G Asp and B O Vessby
      Diabetes Care 1999 Jan; 22 (1): 10-18. https://doi.org/10.2337/diacare.22.1.10

  4. Grosso, N

    1. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.
      G Bruno, A De Salvia, R Arcari, M Borra, N Grosso, Q Carta, M Trovati, M Veglio and G Pagano
      Diabetes Care 1999 Jan; 22 (1): 50-55. https://doi.org/10.2337/diacare.22.1.50

  5. Gunton, J E

    1. Heterozygous hemoglobin Hamadan affects HbA1c assay.
      J E Gunton and A McElduff
      Diabetes Care 1999 Jan; 22 (1): 177. https://doi.org/10.2337/diacare.22.1.177

H

  1. Halimi, S

    1. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
      G Vanzetto, S Halimi, T Hammoud, D Fagret, P Y Benhamou, D Cordonnier, B Denis and J Machecourt
      Diabetes Care 1999 Jan; 22 (1): 19-26. https://doi.org/10.2337/diacare.22.1.19

  2. Hammoud, T

    1. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
      G Vanzetto, S Halimi, T Hammoud, D Fagret, P Y Benhamou, D Cordonnier, B Denis and J Machecourt
      Diabetes Care 1999 Jan; 22 (1): 19-26. https://doi.org/10.2337/diacare.22.1.19

  3. Harris, D A

    1. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.
      A Mohn, K A Matyka, D A Harris, K M Ross, J A Edge and D B Dunger
      Diabetes Care 1999 Jan; 22 (1): 27-32. https://doi.org/10.2337/diacare.22.1.27

  4. Herman, W H

    1. Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes.
      R Sikka, J Waters, W Moore, D R Sutton, W H Herman and R E Aubert
      Diabetes Care 1999 Jan; 22 (1): 1-6. https://doi.org/10.2337/diacare.22.1.1

  5. Hopkins, H

    1. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
      R Moses, R Slobodniuk, S Boyages, S Colagiuri, W Kidson, J Carter, T Donnelly, P Moffitt and H Hopkins
      Diabetes Care 1999 Jan; 22 (1): 119-124. https://doi.org/10.2337/diacare.22.1.119

I

  1. Imperial, J

    1. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
      D A Ehrmann, R B Barnes, R L Rosenfield, M K Cavaghan and J Imperial
      Diabetes Care 1999 Jan; 22 (1): 141-146. https://doi.org/10.2337/diacare.22.1.141

  2. Ishikawa, Y

    1. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
      N Watanabe, T Taniguchi, H Taketoh, Y Kitagawa, H Namura, N Yoneda, Y Kurimoto, S Yamada and Y Ishikawa
      Diabetes Care 1999 Jan; 22 (1): 152-156. https://doi.org/10.2337/diacare.22.1.152

J

  1. Järvi, A E

    1. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.
      A E Järvi, B E Karlström, Y E Granfeldt, I E Björck, N G Asp and B O Vessby
      Diabetes Care 1999 Jan; 22 (1): 10-18. https://doi.org/10.2337/diacare.22.1.10

  2. Jervell, J

    1. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.
      J V Bjørnholt, G Erikssen, E Aaser, L Sandvik, S Nitter-Hauge, J Jervell, J Erikssen and E Thaulow
      Diabetes Care 1999 Jan; 22 (1): 45-49. https://doi.org/10.2337/diacare.22.1.45

  3. Johansen, K

    1. Efficacy of metformin in the treatment of NIDDM. Meta-analysis.
      K Johansen
      Diabetes Care 1999 Jan; 22 (1): 33-37. https://doi.org/10.2337/diacare.22.1.33

  4. Jörneskog, G

    1. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers.
      M Kalani, K Brismar, B Fagrell, J Ostergren and G Jörneskog
      Diabetes Care 1999 Jan; 22 (1): 147-151. https://doi.org/10.2337/diacare.22.1.147

K

  1. Kalani, M

    1. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers.
      M Kalani, K Brismar, B Fagrell, J Ostergren and G Jörneskog
      Diabetes Care 1999 Jan; 22 (1): 147-151. https://doi.org/10.2337/diacare.22.1.147

  2. Karlström, B E

    1. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.
      A E Järvi, B E Karlström, Y E Granfeldt, I E Björck, N G Asp and B O Vessby
      Diabetes Care 1999 Jan; 22 (1): 10-18. https://doi.org/10.2337/diacare.22.1.10

  3. Kekäläinen, P

    1. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes.
      P Kekäläinen, H Sarlund, K Pyörälä and M Laakso
      Diabetes Care 1999 Jan; 22 (1): 86-92. https://doi.org/10.2337/diacare.22.1.86

  4. Kidson, W

    1. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
      R Moses, R Slobodniuk, S Boyages, S Colagiuri, W Kidson, J Carter, T Donnelly, P Moffitt and H Hopkins
      Diabetes Care 1999 Jan; 22 (1): 119-124. https://doi.org/10.2337/diacare.22.1.119

  5. Kitagawa, Y

    1. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
      N Watanabe, T Taniguchi, H Taketoh, Y Kitagawa, H Namura, N Yoneda, Y Kurimoto, S Yamada and Y Ishikawa
      Diabetes Care 1999 Jan; 22 (1): 152-156. https://doi.org/10.2337/diacare.22.1.152

  6. Kurimoto, Y

    1. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
      N Watanabe, T Taniguchi, H Taketoh, Y Kitagawa, H Namura, N Yoneda, Y Kurimoto, S Yamada and Y Ishikawa
      Diabetes Care 1999 Jan; 22 (1): 152-156. https://doi.org/10.2337/diacare.22.1.152

  7. Kushner, H

    1. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
      A E Sumner, H Kushner, K D Sherif, T N Tulenko, B Falkner and J B Marsh
      Diabetes Care 1999 Jan; 22 (1): 71-77. https://doi.org/10.2337/diacare.22.1.71

L

  1. Laakso, M

    1. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes.
      P Kekäläinen, H Sarlund, K Pyörälä and M Laakso
      Diabetes Care 1999 Jan; 22 (1): 86-92. https://doi.org/10.2337/diacare.22.1.86

  2. Lavery, L A

    1. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
      G E Reiber, L Vileikyte, E J Boyko, M del Aguila, D G Smith, L A Lavery and A J Boulton
      Diabetes Care 1999 Jan; 22 (1): 157-162. https://doi.org/10.2337/diacare.22.1.157

  3. Leonnetti, D L

    1. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans.
      M J McNeely, E J Boyko, D S Weigle, J B Shofer, S D Chessler, D L Leonnetti and W Y Fujimoto
      Diabetes Care 1999 Jan; 22 (1): 65-70. https://doi.org/10.2337/diacare.22.1.65

  4. Li, S

    1. Social environment and year of birth influence type 1 diabetes risk for African-American and Latino children.
      R B Lipton, M Drum, S Li and H Choi
      Diabetes Care 1999 Jan; 22 (1): 78-85. https://doi.org/10.2337/diacare.22.1.78

  5. Lièvre, M

    1. Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients.
      M Lièvre and M Marre
      Diabetes Care 1999 Jan; 22 (1): 178-179. https://doi.org/10.2337/diacare.22.1.178a

  6. Lipton, R B

    1. Social environment and year of birth influence type 1 diabetes risk for African-American and Latino children.
      R B Lipton, M Drum, S Li and H Choi
      Diabetes Care 1999 Jan; 22 (1): 78-85. https://doi.org/10.2337/diacare.22.1.78

  7. Lteif, A N

    1. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes.
      A N Lteif and W F Schwenk
      Diabetes Care 1999 Jan; 22 (1): 137-140. https://doi.org/10.2337/diacare.22.1.137

M

  1. Machecourt, J

    1. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
      G Vanzetto, S Halimi, T Hammoud, D Fagret, P Y Benhamou, D Cordonnier, B Denis and J Machecourt
      Diabetes Care 1999 Jan; 22 (1): 19-26. https://doi.org/10.2337/diacare.22.1.19

  2. Marre, M

    1. Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients.
      M Lièvre and M Marre
      Diabetes Care 1999 Jan; 22 (1): 178-179. https://doi.org/10.2337/diacare.22.1.178a

  3. Marsh, J B

    1. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
      A E Sumner, H Kushner, K D Sherif, T N Tulenko, B Falkner and J B Marsh
      Diabetes Care 1999 Jan; 22 (1): 71-77. https://doi.org/10.2337/diacare.22.1.71

  4. Matyka, K A

    1. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.
      A Mohn, K A Matyka, D A Harris, K M Ross, J A Edge and D B Dunger
      Diabetes Care 1999 Jan; 22 (1): 27-32. https://doi.org/10.2337/diacare.22.1.27

  5. McElduff, A

    1. Heterozygous hemoglobin Hamadan affects HbA1c assay.
      J E Gunton and A McElduff
      Diabetes Care 1999 Jan; 22 (1): 177. https://doi.org/10.2337/diacare.22.1.177

  6. McNeely, M J

    1. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans.
      M J McNeely, E J Boyko, D S Weigle, J B Shofer, S D Chessler, D L Leonnetti and W Y Fujimoto
      Diabetes Care 1999 Jan; 22 (1): 65-70. https://doi.org/10.2337/diacare.22.1.65

  7. Meneilly, G S

    1. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
      G S Meneilly and T Elliott
      Diabetes Care 1999 Jan; 22 (1): 112-118. https://doi.org/10.2337/diacare.22.1.112

  8. Moffitt, P

    1. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
      R Moses, R Slobodniuk, S Boyages, S Colagiuri, W Kidson, J Carter, T Donnelly, P Moffitt and H Hopkins
      Diabetes Care 1999 Jan; 22 (1): 119-124. https://doi.org/10.2337/diacare.22.1.119

  9. Mohn, A

    1. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.
      A Mohn, K A Matyka, D A Harris, K M Ross, J A Edge and D B Dunger
      Diabetes Care 1999 Jan; 22 (1): 27-32. https://doi.org/10.2337/diacare.22.1.27

  10. Moore, W

    1. Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes.
      R Sikka, J Waters, W Moore, D R Sutton, W H Herman and R E Aubert
      Diabetes Care 1999 Jan; 22 (1): 1-6. https://doi.org/10.2337/diacare.22.1.1

  11. Moses, R

    1. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
      R Moses, R Slobodniuk, S Boyages, S Colagiuri, W Kidson, J Carter, T Donnelly, P Moffitt and H Hopkins
      Diabetes Care 1999 Jan; 22 (1): 119-124. https://doi.org/10.2337/diacare.22.1.119

  12. Muntoni, S

    1. Metformin and fatty acids.
      S Muntoni
      Diabetes Care 1999 Jan; 22 (1): 179-180. https://doi.org/10.2337/diacare.22.1.179

N

  1. Namura, H

    1. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
      N Watanabe, T Taniguchi, H Taketoh, Y Kitagawa, H Namura, N Yoneda, Y Kurimoto, S Yamada and Y Ishikawa
      Diabetes Care 1999 Jan; 22 (1): 152-156. https://doi.org/10.2337/diacare.22.1.152

  2. Nitter-Hauge, S

    1. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.
      J V Bjørnholt, G Erikssen, E Aaser, L Sandvik, S Nitter-Hauge, J Jervell, J Erikssen and E Thaulow
      Diabetes Care 1999 Jan; 22 (1): 45-49. https://doi.org/10.2337/diacare.22.1.45

O

  1. O'Shea, D

    1. Lactic acidosis with therapeutic metformin blood level in a low-risk diabetic patient.
      N N Chan, D Darko and D O'Shea
      Diabetes Care 1999 Jan; 22 (1): 178. https://doi.org/10.2337/diacare.22.1.178b

  2. Odekerken, D A

    1. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
      Y M Smulders, M Rakic, E H Slaats, M Treskes, E J Sijbrands, D A Odekerken, C D Stehouwer and J Silberbusch
      Diabetes Care 1999 Jan; 22 (1): 125-132. https://doi.org/10.2337/diacare.22.1.125

  3. Ostergren, J

    1. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers.
      M Kalani, K Brismar, B Fagrell, J Ostergren and G Jörneskog
      Diabetes Care 1999 Jan; 22 (1): 147-151. https://doi.org/10.2337/diacare.22.1.147

P

  1. Pagano, G

    1. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.
      G Bruno, A De Salvia, R Arcari, M Borra, N Grosso, Q Carta, M Trovati, M Veglio and G Pagano
      Diabetes Care 1999 Jan; 22 (1): 50-55. https://doi.org/10.2337/diacare.22.1.50

  2. Pyörälä, K

    1. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes.
      P Kekäläinen, H Sarlund, K Pyörälä and M Laakso
      Diabetes Care 1999 Jan; 22 (1): 86-92. https://doi.org/10.2337/diacare.22.1.86

R

  1. Rakic, M

    1. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
      Y M Smulders, M Rakic, E H Slaats, M Treskes, E J Sijbrands, D A Odekerken, C D Stehouwer and J Silberbusch
      Diabetes Care 1999 Jan; 22 (1): 125-132. https://doi.org/10.2337/diacare.22.1.125

  2. Ramachandran, A

    1. GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years.
      A Ramachandran, C Snehalatha, K Satyavani, S Sivasankari and V Vijay
      Diabetes Care 1999 Jan; 22 (1): 175-176. https://doi.org/10.2337/diacare.22.1.175

  3. Rassam, A G

    1. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
      A G Rassam, T M Zeise, M R Burge and D S Schade
      Diabetes Care 1999 Jan; 22 (1): 133-136. https://doi.org/10.2337/diacare.22.1.133

  4. Reiber, G E

    1. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
      G E Reiber, L Vileikyte, E J Boyko, M del Aguila, D G Smith, L A Lavery and A J Boulton
      Diabetes Care 1999 Jan; 22 (1): 157-162. https://doi.org/10.2337/diacare.22.1.157

  5. Rogantin, F

    1. Diabetic ketoacidosis associated with clozapine treatment.
      A Colli, M Cocciolo, F Francobandiera, F Rogantin and N Cattalini
      Diabetes Care 1999 Jan; 22 (1): 176-177. https://doi.org/10.2337/diacare.22.1.176a

  6. Rosenfield, R L

    1. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
      D A Ehrmann, R B Barnes, R L Rosenfield, M K Cavaghan and J Imperial
      Diabetes Care 1999 Jan; 22 (1): 141-146. https://doi.org/10.2337/diacare.22.1.141

  7. Ross, K M

    1. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.
      A Mohn, K A Matyka, D A Harris, K M Ross, J A Edge and D B Dunger
      Diabetes Care 1999 Jan; 22 (1): 27-32. https://doi.org/10.2337/diacare.22.1.27

S

  1. Sandvik, L

    1. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.
      J V Bjørnholt, G Erikssen, E Aaser, L Sandvik, S Nitter-Hauge, J Jervell, J Erikssen and E Thaulow
      Diabetes Care 1999 Jan; 22 (1): 45-49. https://doi.org/10.2337/diacare.22.1.45

  2. Sarlund, H

    1. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes.
      P Kekäläinen, H Sarlund, K Pyörälä and M Laakso
      Diabetes Care 1999 Jan; 22 (1): 86-92. https://doi.org/10.2337/diacare.22.1.86

  3. Satyavani, K

    1. GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years.
      A Ramachandran, C Snehalatha, K Satyavani, S Sivasankari and V Vijay
      Diabetes Care 1999 Jan; 22 (1): 175-176. https://doi.org/10.2337/diacare.22.1.175

  4. Schade, D S

    1. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
      A G Rassam, T M Zeise, M R Burge and D S Schade
      Diabetes Care 1999 Jan; 22 (1): 133-136. https://doi.org/10.2337/diacare.22.1.133

  5. Schwenk, W F

    1. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes.
      A N Lteif and W F Schwenk
      Diabetes Care 1999 Jan; 22 (1): 137-140. https://doi.org/10.2337/diacare.22.1.137

  6. Selby, J V

    1. First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization.
      J V Selby, B Ettinger, B E Swain and J B Brown
      Diabetes Care 1999 Jan; 22 (1): 38-44. https://doi.org/10.2337/diacare.22.1.38

  7. Sherif, K D

    1. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
      A E Sumner, H Kushner, K D Sherif, T N Tulenko, B Falkner and J B Marsh
      Diabetes Care 1999 Jan; 22 (1): 71-77. https://doi.org/10.2337/diacare.22.1.71

  8. Shofer, J B

    1. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans.
      M J McNeely, E J Boyko, D S Weigle, J B Shofer, S D Chessler, D L Leonnetti and W Y Fujimoto
      Diabetes Care 1999 Jan; 22 (1): 65-70. https://doi.org/10.2337/diacare.22.1.65

  9. Sijbrands, E J

    1. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
      Y M Smulders, M Rakic, E H Slaats, M Treskes, E J Sijbrands, D A Odekerken, C D Stehouwer and J Silberbusch
      Diabetes Care 1999 Jan; 22 (1): 125-132. https://doi.org/10.2337/diacare.22.1.125

  10. Sikka, R

    1. Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes.
      R Sikka, J Waters, W Moore, D R Sutton, W H Herman and R E Aubert
      Diabetes Care 1999 Jan; 22 (1): 1-6. https://doi.org/10.2337/diacare.22.1.1

  11. Silberbusch, J

    1. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
      Y M Smulders, M Rakic, E H Slaats, M Treskes, E J Sijbrands, D A Odekerken, C D Stehouwer and J Silberbusch
      Diabetes Care 1999 Jan; 22 (1): 125-132. https://doi.org/10.2337/diacare.22.1.125

  12. Sivasankari, S

    1. GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years.
      A Ramachandran, C Snehalatha, K Satyavani, S Sivasankari and V Vijay
      Diabetes Care 1999 Jan; 22 (1): 175-176. https://doi.org/10.2337/diacare.22.1.175

  13. Slaats, E H

    1. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
      Y M Smulders, M Rakic, E H Slaats, M Treskes, E J Sijbrands, D A Odekerken, C D Stehouwer and J Silberbusch
      Diabetes Care 1999 Jan; 22 (1): 125-132. https://doi.org/10.2337/diacare.22.1.125

  14. Slobodniuk, R

    1. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
      R Moses, R Slobodniuk, S Boyages, S Colagiuri, W Kidson, J Carter, T Donnelly, P Moffitt and H Hopkins
      Diabetes Care 1999 Jan; 22 (1): 119-124. https://doi.org/10.2337/diacare.22.1.119

  15. Smith, D G

    1. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
      G E Reiber, L Vileikyte, E J Boyko, M del Aguila, D G Smith, L A Lavery and A J Boulton
      Diabetes Care 1999 Jan; 22 (1): 157-162. https://doi.org/10.2337/diacare.22.1.157

  16. Smulders, Y M

    1. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
      Y M Smulders, M Rakic, E H Slaats, M Treskes, E J Sijbrands, D A Odekerken, C D Stehouwer and J Silberbusch
      Diabetes Care 1999 Jan; 22 (1): 125-132. https://doi.org/10.2337/diacare.22.1.125

  17. Snehalatha, C

    1. GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years.
      A Ramachandran, C Snehalatha, K Satyavani, S Sivasankari and V Vijay
      Diabetes Care 1999 Jan; 22 (1): 175-176. https://doi.org/10.2337/diacare.22.1.175

  18. Stehouwer, C D

    1. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
      Y M Smulders, M Rakic, E H Slaats, M Treskes, E J Sijbrands, D A Odekerken, C D Stehouwer and J Silberbusch
      Diabetes Care 1999 Jan; 22 (1): 125-132. https://doi.org/10.2337/diacare.22.1.125

  19. Stolk, R P

    1. Prevalence of deafness is increased in patients with type 2 diabetes in The Netherlands.
      R P Stolk and L J Boomsma
      Diabetes Care 1999 Jan; 22 (1): 180. https://doi.org/10.2337/diacare.22.1.180

  20. Sumner, A E

    1. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
      A E Sumner, H Kushner, K D Sherif, T N Tulenko, B Falkner and J B Marsh
      Diabetes Care 1999 Jan; 22 (1): 71-77. https://doi.org/10.2337/diacare.22.1.71

  21. Sutton, D R

    1. Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes.
      R Sikka, J Waters, W Moore, D R Sutton, W H Herman and R E Aubert
      Diabetes Care 1999 Jan; 22 (1): 1-6. https://doi.org/10.2337/diacare.22.1.1

  22. Swain, B E

    1. First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization.
      J V Selby, B Ettinger, B E Swain and J B Brown
      Diabetes Care 1999 Jan; 22 (1): 38-44. https://doi.org/10.2337/diacare.22.1.38

T

  1. Taketoh, H

    1. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
      N Watanabe, T Taniguchi, H Taketoh, Y Kitagawa, H Namura, N Yoneda, Y Kurimoto, S Yamada and Y Ishikawa
      Diabetes Care 1999 Jan; 22 (1): 152-156. https://doi.org/10.2337/diacare.22.1.152

  2. Taniguchi, T

    1. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
      N Watanabe, T Taniguchi, H Taketoh, Y Kitagawa, H Namura, N Yoneda, Y Kurimoto, S Yamada and Y Ishikawa
      Diabetes Care 1999 Jan; 22 (1): 152-156. https://doi.org/10.2337/diacare.22.1.152

  3. Thaulow, E

    1. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.
      J V Bjørnholt, G Erikssen, E Aaser, L Sandvik, S Nitter-Hauge, J Jervell, J Erikssen and E Thaulow
      Diabetes Care 1999 Jan; 22 (1): 45-49. https://doi.org/10.2337/diacare.22.1.45

  4. Treskes, M

    1. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
      Y M Smulders, M Rakic, E H Slaats, M Treskes, E J Sijbrands, D A Odekerken, C D Stehouwer and J Silberbusch
      Diabetes Care 1999 Jan; 22 (1): 125-132. https://doi.org/10.2337/diacare.22.1.125

  5. Trovati, M

    1. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.
      G Bruno, A De Salvia, R Arcari, M Borra, N Grosso, Q Carta, M Trovati, M Veglio and G Pagano
      Diabetes Care 1999 Jan; 22 (1): 50-55. https://doi.org/10.2337/diacare.22.1.50

  6. Tulenko, T N

    1. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
      A E Sumner, H Kushner, K D Sherif, T N Tulenko, B Falkner and J B Marsh
      Diabetes Care 1999 Jan; 22 (1): 71-77. https://doi.org/10.2337/diacare.22.1.71

V

  1. Vanelli, M

    1. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices.
      M Vanelli, G Chiari, L Ghizzoni, G Costi, T Giacalone and F Chiarelli
      Diabetes Care 1999 Jan; 22 (1): 7-9. https://doi.org/10.2337/diacare.22.1.7

  2. Vanzetto, G

    1. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
      G Vanzetto, S Halimi, T Hammoud, D Fagret, P Y Benhamou, D Cordonnier, B Denis and J Machecourt
      Diabetes Care 1999 Jan; 22 (1): 19-26. https://doi.org/10.2337/diacare.22.1.19

  3. Veglio, M

    1. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.
      G Bruno, A De Salvia, R Arcari, M Borra, N Grosso, Q Carta, M Trovati, M Veglio and G Pagano
      Diabetes Care 1999 Jan; 22 (1): 50-55. https://doi.org/10.2337/diacare.22.1.50

  4. Vessby, B O

    1. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.
      A E Järvi, B E Karlström, Y E Granfeldt, I E Björck, N G Asp and B O Vessby
      Diabetes Care 1999 Jan; 22 (1): 10-18. https://doi.org/10.2337/diacare.22.1.10

  5. Vijay, V

    1. GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years.
      A Ramachandran, C Snehalatha, K Satyavani, S Sivasankari and V Vijay
      Diabetes Care 1999 Jan; 22 (1): 175-176. https://doi.org/10.2337/diacare.22.1.175

  6. Vileikyte, L

    1. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
      G E Reiber, L Vileikyte, E J Boyko, M del Aguila, D G Smith, L A Lavery and A J Boulton
      Diabetes Care 1999 Jan; 22 (1): 157-162. https://doi.org/10.2337/diacare.22.1.157

W

  1. Watanabe, N

    1. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
      N Watanabe, T Taniguchi, H Taketoh, Y Kitagawa, H Namura, N Yoneda, Y Kurimoto, S Yamada and Y Ishikawa
      Diabetes Care 1999 Jan; 22 (1): 152-156. https://doi.org/10.2337/diacare.22.1.152

  2. Waters, J

    1. Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes.
      R Sikka, J Waters, W Moore, D R Sutton, W H Herman and R E Aubert
      Diabetes Care 1999 Jan; 22 (1): 1-6. https://doi.org/10.2337/diacare.22.1.1

  3. Weigle, D S

    1. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans.
      M J McNeely, E J Boyko, D S Weigle, J B Shofer, S D Chessler, D L Leonnetti and W Y Fujimoto
      Diabetes Care 1999 Jan; 22 (1): 65-70. https://doi.org/10.2337/diacare.22.1.65

  4. Wendorf, M

    1. Thrifty gene and hunting as a way of life are evident in a Paleoindian burial.
      M Wendorf
      Diabetes Care 1999 Jan; 22 (1): 176. https://doi.org/10.2337/diacare.22.1.176b

  5. Wollesen, F

    1. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
      F Wollesen, G Dahlén, L Berglund and C Berne
      Diabetes Care 1999 Jan; 22 (1): 93-98. https://doi.org/10.2337/diacare.22.1.93

Y

  1. Yamada, S

    1. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
      N Watanabe, T Taniguchi, H Taketoh, Y Kitagawa, H Namura, N Yoneda, Y Kurimoto, S Yamada and Y Ishikawa
      Diabetes Care 1999 Jan; 22 (1): 152-156. https://doi.org/10.2337/diacare.22.1.152

  2. Yoneda, N

    1. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
      N Watanabe, T Taniguchi, H Taketoh, Y Kitagawa, H Namura, N Yoneda, Y Kurimoto, S Yamada and Y Ishikawa
      Diabetes Care 1999 Jan; 22 (1): 152-156. https://doi.org/10.2337/diacare.22.1.152

Z

  1. Zeise, T M

    1. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
      A G Rassam, T M Zeise, M R Burge and D S Schade
      Diabetes Care 1999 Jan; 22 (1): 133-136. https://doi.org/10.2337/diacare.22.1.133
Back to top